| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Carmell Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.06 |
| 52 Week High | US$13.31 |
| 52 Week Low | US$1.70 |
| Beta | 0.31 |
| 1 Month Change | -23.56% |
| 3 Month Change | -48.50% |
| 1 Year Change | -79.78% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -78.87% |
Recent News & Updates
Shareholder Returns
| CTCX | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0.5% | 1.3% | 3.3% |
| 1Y | -79.8% | 3.0% | 25.0% |
Return vs Industry: CTCX underperformed the US Biotechs industry which returned 3.4% over the past year.
Return vs Market: CTCX underperformed the US Market which returned 25.8% over the past year.
Price Volatility
| CTCX volatility | |
|---|---|
| CTCX Average Weekly Movement | 20.0% |
| Biotechs Industry Average Movement | 11.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CTCX's share price has been volatile over the past 3 months.
Volatility Over Time: CTCX's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 10 | Rajiv Shukla | www.carmellcosmetics.com |
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks.
Carmell Corporation Fundamentals Summary
| CTCX fundamental statistics | |
|---|---|
| Market cap | US$55.22m |
| Earnings (TTM) | -US$16.88m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-3.3x
P/E RatioIs CTCX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CTCX income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$16.88m |
| Earnings | -US$16.88m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.63 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 5.2% |
How did CTCX perform over the long term?
See historical performance and comparison